Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 04, 2024
Merck announced that the National Medical Products Administration (NMPA) in China has approved WELIREG® (belzutifan), for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (...
read more
SK Capital has signed a definitive agreement to acquire Perrigo API business.
read more
Minaris, a CGT CDMO and multimodality biosafety testing provider and Chimeric Therapeutics, an Australian cell therapy company, announced a 100% batch manufacturing and release success rate in support of Chimeric Therapeutics' CDH17-targeted ...
read more
Bachem has announced major investmenta across their site network, with new funding to improve production facilities at their Bubendorf, Vista and St Helens sites, along with a new site in Sisseln.
read more
Uniphar has launched Uniphar | Global Sourcing, a new identity for its On Demand business that strengthens its position as a strategic sourcing partner across international healthcare markets.
read more
Tuesday, January 05, 2021
miRagen has gained exclusive rights to develop and commercialize therapeutic antibodies targeting IGF-1R incorporating Xtend Fc technology from Xencor.
read more
Tuesday, September 17, 2013
Piramal | Healthcare today announced that it is to invest 11 million USD at its Morpeth, UK facility to triple the production capacity for hormonal products, including contraceptive pills and hormone replacement therapies. The expansion, which has ...
read more
Recipharm has completeted the acquisition of OnTarget Chemistry in Uppsala, Sweden. OnTarget Chemistry is a fast growing CRO company with a turnover in 2014 of close to SEK 29 million that is specialized in medicinal chemistry offering synthesis and ...
read more
Berkshire Sterile Manufacturing (BSM) recently completed their first GMP fill using their new low loss fill process.
read more
Wednesday, March 10, 2021
IONTAS and FairJourney Biologics have announced that they have entered into an agreement with Quell Therapeutics regarding IONTAS / FJB’s proprietary libraries and technology platforms.
read more
Thursday, September 22, 2022
Bora Pharmaceutical Labs, a division of Bora Pharmaceuticals, partnered with TaiRx, a Taiwanese drug development company, to manufacture a novel anticancer drug, CVM-1118.
read more
ABEC announced large-scale single-use microbial fermentation capability. ABEC’s CSR technology has demonstrated state-of-the-art performance with working volumes up to 1,000 liters.
read more
Wednesday, August 28, 2019
Bone Solutions announces a private label licensing agreement with Onkos Surgical covering OsteoCrete® technology designed to assist with bone repair and regeneration.
read more
Friday, November 15, 2019
Syneos Health announced the appointment of Bernadette Connaughton to the Company’s Board of Directors.
read more
Catalent, Inc. announced changes to its operating structure and executive leadership team that went into effect July 1. This new organizational structure includes a shift from four reporting segments to two, each representing roughly half of the ...
read more